Cann Group has agreed to supply Levin Health with additional flower products valued at around A$1.58 million further to an agreement announced in June.
Cann will now supply a total of $2.29m in flower products and $850,000-worth of oils to Levin during H1 FY23.
CEO Peter Koetsier said: “Securing longer-term supply agreements with our preferred partners is a critical component of the Cann Group strategy for the future.
“Cann recognises the importance of establishing stable and reliable supply chains using our TGO93-compliant cultivation and production facility to meet the evolving demands of our customers.
“Through this, we believe we can enhance our competitive advantage and position ourselves as a trusted and dependable partner in the industry.”
